Cited by 297SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations

Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality

Open access
Zohar, Tomer, Loos, Carolin, Fischinger, Stephanie, Atyeo, Caroline, Wang, Chuangqi, Slein, Matthew D., Burke, John, Yu, Jingyou +11 more·2020·Cell

Abstract

The urgent need for an effective SARS-CoV-2 vaccine has forced development to progress in the absence of well-defined correlates of immunity. While neutralization has been linked to protection against other pathogens, whether neutralization alone will be sufficient to drive protection against SARS-CoV-2 in the broader population remains unclear. Therefore, to fully define protective humoral immunity, we dissected the early evolution of the humoral response in 193 hospitalized individuals ranging from moderate to severe. Although robust IgM and IgA responses evolved in both survivors and non-survivors with severe disease, non-survivors showed attenuated IgG responses, accompanied by compromised Fcɣ receptor binding and Fc effector activity, pointing to deficient humoral development rather than disease-enhancing humoral immunity. In contrast, individuals with moderate disease exhibited delayed responses that ultimately matured. These data highlight distinct humoral trajectories associated with resolution of SARS-CoV-2 infection and the need for early functional humoral immunity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.10.052

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Neutralization measurement does not account for Fc effector functions; Fcγ receptor or complement engagement by antibodies could confer protection.

    “this measurement does not account for Fc effector functions; Fcγ receptor or complement protein engagement by non-, weakly-, or strongly- neutralizing antibodies that bind the SARS-CoV-2 spike protein on the surface of infected cells could confer substantial protection39–41.”
  • A bias toward nucleocapsid antibodies over Spike antibodies in fatal cases is consistent with a role for Spike antibodies in reducing viral loads.

    “A bias toward nucleocapsid antibodies over Spike antibodies in fatal cases was observed in a pair of studies (Atyeo et al., 2020; Zohar et al., 2020), which is consistent with a role for Spike antibodies in reducing viral loads.”

    From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Zohar et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Pesarin F. Salmaso L. Permutation Tests for Complex Data 2010 John Wiley & Sons, Ltd

Cited by

Sorted by citations

Authors
Zohar, T., Loos, C., Fischinger, S., Atyeo, C., Wang, C., Slein, M. D., Burke, J., Yu, J., Feldman, J., Hauser, B. M., Caradonna, T., Schmidt, A. G., Cai, Y., Streeck, H., Ryan, E. T., Barouch, D. H., Charles, R. C., Lauffenburger, D. A., & Alter, G.
Affiliations
  • Ragon Institute of MGH, MIT and Harvard (US)
  • Harvard University (US)
  • Massachusetts Institute of Technology (US)
  • Beth Israel Deaconess Medical Center (US)
  • Boston Children's Hospital (US)
  • University of Bonn (DE)
Corresponding author
  • Charles, Richelle C.
  • Lauffenburger, Douglas A.
  • Alter, Galit
Venue
Cell
Publisher
Elsevier BV
Published
2020-12
Volume
183
Issue
6
Pages
1508-1519.e12
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3095217725
Cited by
297
References
56
Citations by year
2026: 11 · 2025: 20 · 2024: 38 · 2023: 43 · 2022: 97 · 2021: 81 · 2020: 6
FWCI
7.45
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ImmPort
Funders
  • National Institute of Allergy and Infectious Diseases
  • Centers for Disease Control and Prevention
  • Massachusetts General Hospital
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
SARS-CoV-2, humoral immunity, neutralizing antibodies, IgG antibody response, Fcγ receptor binding, Fc effector functions, COVID-19 mortality, hospitalized patients, disease severity, antibody kinetics, vaccine correlates of protection
MeSH terms
COVID-19, SARS-CoV-2, Female, Humans, Immunoglobulin A, Immunoglobulin M, Male, Receptors, IgG, HL-60 Cells, Immunity, Humoral

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review